Rampart Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-664
| Closed | -$372K | – | 294 |
|
|
2020
Q3 | $372K | Sell |
664
-1,375
| -67% | -$770K | 0.24% | 104 |
|
|
2020
Q2 | $1.27M | Buy |
2,039
+879
| +76% | +$548K | 0.21% | 136 |
|
|
2020
Q1 | $566K | Buy |
1,160
+226
| +24% | +$110K | 0.27% | 82 |
|
|
2019
Q4 | $351K | Buy |
934
+43
| +5% | +$16.2K | 0.04% | 369 |
|
|
2019
Q3 | $247K | Sell |
891
-17
| -2% | -$4.71K | 0.03% | 403 |
|
|
2019
Q2 | $284K | Sell |
908
-40
| -4% | -$12.5K | 0.03% | 398 |
|
|
2019
Q1 | $389K | Buy |
948
+144
| +18% | +$59.1K | 0.04% | 354 |
|
|
2018
Q4 | $300K | Sell |
804
-1,778
| -69% | -$663K | 0.08% | 208 |
|
|
2018
Q3 | $348K | Sell |
2,582
-699
| -21% | -$94.1K | 0.15% | 152 |
|
|
2018
Q2 | $1.13M | Buy |
3,281
+1,216
| +59% | +$420K | 0.11% | 252 |
|
|
2018
Q1 | $711K | Buy |
2,065
+1,124
| +119% | +$387K | 0.07% | 290 |
|
|
2017
Q4 | $354K | Sell |
941
-98
| -9% | -$36.9K | 0.14% | 173 |
|
|
2017
Q3 | $465K | Buy |
1,039
+56
| +6% | +$25.1K | 0.16% | 152 |
|
|
2017
Q2 | $483K | Buy |
983
+775
| +373% | +$381K | 0.17% | 133 |
|
|
2017
Q1 | $81K | Sell |
208
-1,251
| -86% | -$487K | 0.03% | 178 |
|
|
2016
Q4 | $536K | Sell |
1,459
-5
| -0.3% | -$1.84K | 0.19% | 94 |
|
|
2016
Q3 | $589K | Buy |
+1,464
| New | +$589K | 0.23% | 87 |
|